心血管

订阅

MedSci主页 / 所有栏目 / 心血管

血管竟然可以这样疏通！！！

2016-07-07 佚名 腾讯视频

血管PCI
关注

导语：点播放后，根本停不下来。 点击图片，即可跳转进入视频观看界面，请处于WiFi条件下观看，土豪随意。

导语：点播放后，根本停不下来。




点击图片，即可跳转进入视频观看界面，请处于WiFi条件下观看，土豪随意。

版权声明：
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于williamhill asia 医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章，或“williamhill asia 号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系，williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=146984, encodeId=e85b1469842a, content=谢谢指点学习谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Oct 12 16:14:45 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92484, encodeId=d44292484b6, content=很赞啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 09 17:02:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92317, encodeId=3c9a9231e7c, content=可以啊！, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Jul 07 21:50:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92227, encodeId=d8c49222ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Thu Jul 07 13:30:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92216, encodeId=c37192216b0, content=脑洞无极限, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Thu Jul 07 12:25:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-10-12 1e0ece0dm09(暂无匿称)

    谢谢指点学习谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=146984, encodeId=e85b1469842a, content=谢谢指点学习谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Oct 12 16:14:45 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92484, encodeId=d44292484b6, content=很赞啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 09 17:02:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92317, encodeId=3c9a9231e7c, content=可以啊！, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Jul 07 21:50:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92227, encodeId=d8c49222ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Thu Jul 07 13:30:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92216, encodeId=c37192216b0, content=脑洞无极限, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Thu Jul 07 12:25:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-07-09 oo902

    很赞啊

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=146984, encodeId=e85b1469842a, content=谢谢指点学习谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Oct 12 16:14:45 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92484, encodeId=d44292484b6, content=很赞啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 09 17:02:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92317, encodeId=3c9a9231e7c, content=可以啊！, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Jul 07 21:50:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92227, encodeId=d8c49222ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Thu Jul 07 13:30:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92216, encodeId=c37192216b0, content=脑洞无极限, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Thu Jul 07 12:25:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-07-07 jaysppr

    可以啊！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=146984, encodeId=e85b1469842a, content=谢谢指点学习谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Oct 12 16:14:45 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92484, encodeId=d44292484b6, content=很赞啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 09 17:02:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92317, encodeId=3c9a9231e7c, content=可以啊！, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Jul 07 21:50:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92227, encodeId=d8c49222ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Thu Jul 07 13:30:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92216, encodeId=c37192216b0, content=脑洞无极限, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Thu Jul 07 12:25:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-07-07 黄庆

    厉害

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=146984, encodeId=e85b1469842a, content=谢谢指点学习谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Oct 12 16:14:45 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92484, encodeId=d44292484b6, content=很赞啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 09 17:02:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92317, encodeId=3c9a9231e7c, content=可以啊！, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Jul 07 21:50:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92227, encodeId=d8c49222ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Thu Jul 07 13:30:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92216, encodeId=c37192216b0, content=脑洞无极限, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Thu Jul 07 12:25:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-07-07 小青虫

    脑洞无极限

    0

相关威廉亚洲官网

BMJ：肝门静脉积气——案例报道

患者女，74岁，因“寒颤、腹部不适2周”就诊。实验室指标提示炎症标志物升高，肝功表现为胆汁淤积。腹部超声和磁共振胰胆管成像未见明显异常。CT提示：肝门静脉积气(HPVG) ，左腰大肌脓肿。此时患者诊断可明确为：肝门静脉积气。因患者临床表现快速恶化，对其进行了急诊手术。术中发现患者伴有憩室脓肿和肠系膜下静脉破裂。最终对患者进行肠切除术+结肠造口术，术后患者恢复得很好。HPVG指由于各种原因导致气体在

利用谱系示踪技术发现肝脏血管新起源

中科

癌症细胞补给线或为药物研发提供新靶标

图片来源：V. ALTOUNIAN/SCIENCE 如果血管生成拟态的确为转移铺就了道路，那么阻止它就会拯救生命。 2000年3月的一个大冷天，上百位研究人员挤在美国盐湖城一个宾馆的礼堂内，迫切想观看就癌症研究中最具争议性的观点发起的终极对决。一边是爱荷华大学癌症中心癌症生物学家Mary Hendrix。1年前，她的团队报告称，肿瘤细胞能利用血液供应获取营养物质。这是一

5·18血管健康日--血脂10问

作者：河北省人民医院 郭艺芳每年5月18日是“血管健康日”。冠心病与脑中风是对我国居民生命健康危害最大的疾病，这些基本本质上都属于血管疾病。积极筛查并干预血脂异常对于维护血管健康具有重要意义。1、什么是血脂？——血脂是血液中胆固醇、甘油三酯（TG）和类脂的总称。在多数医院所提供的化验单中，血脂检验项目主要包括胆固醇和TG两组参数。总胆固醇（TC）又被分为高密度脂蛋白胆固醇（HDL-C）和低密度

JAHA：创伤后应激障碍患者的血管健康备受影响

一项新研究表明，创伤后应激障碍(PTSD)可能会降低退伍军人血管扩张的能力,增加他们心脏病发作和卒中的风险。研究发表在Journal of the American Heart Association。 这是迄今为止最大规模探究创伤后应激障碍(PTSD)对退伍军人血管健康影响的研究。研究人员发现,相比正常人而言，创伤后应激障碍的退伍军人扩张通血管的能力降低，血管活性降低，出现心脏病和其他严重并发症

Cancer Discovery：癌细胞改造环境从而更容易抵达附近血管

在最近发表于《Cancer Discovery》期刊的新研究中，麻省理工学院（MIT）研究人员揭示了癌细胞在离开原发肿瘤位置时最初采取的步骤。这种扩散并称为转移（metastasis），负责90%的癌症死亡。 在小鼠研究中，研究人员发现，携带被称为MenaINV（侵润性）的特定版本Mena蛋白质的癌细胞，能够改造它们的环境使其更容易迁移到血管中并扩散到整个身体。他们还表明，高水平的这种蛋白质与乳